[Depressive syndromes within the scope of schizophrenic psychoses].
In the present study two groups of 30 patients were compared. The first group included 30 acute schizophrenic patients, who were rated immediately after admission and 3 months later under depot-neuroleptics. The second group consisted of chronic schizophrenic outpatients, who were rated at the beginning of Fluphenazindecanoat-medication and 8 months later. As documentation PSE (present state examination) was used. Psychotic symptoms of the acute schizophrenic patients could be influenced well by the treatment, not in the same way, however, depressive and neurotic symptoms. The frequency of psychotic symptoms is lower in chronic schizophrenics than in acute ones at the beginning of therapy. 8 months later there are little more psychotic symptoms in chronic patients than in acute schizophrenics; the depressive symptoms follow the same design in a lower extant however. The scores of depressive symptoms in the acute-group are similar to those of chronic schizophrenics and do not change significantly in the course of 8 months lasting depot-neuroleptic therapy. Another study could show 1982, that 67 outpatients from 87 in the year 1972 still were in psychiatric care and control, 23% of them received antidepressiva because of depressive symptoms in connection with residual syndromes and only 4% because of exhaustion-syndromes after remission of the disease.
D003866:Depressive Disorder / Q000150:complications*; D005476:Fluphenazine / Q000031:analogs & derivatives / Q000627:therapeutic use; D006212:Hallucinations / Q000150:complications; D006801:Humans; D008134:Long-Term Care; D008297:Male; D008960:Models, Psychological; D011618:Psychotic Disorders / Q000188:drug therapy; D012559:Schizophrenia / Q000150:complications*; D013577:Syndrome
C011825:fluphenazine depot; D005476:Fluphenazine
Depressive Syndrome im Rahmen schizophrener Psychosen.